NON-PRESSURIZED FOAM PROJECT
KINODIN supports private label 5% minoxidil pump-foam projects for qualified brands, distributors and pharmaceutical partners seeking a non-pressurized dispensing format. The formula, concentration basis, foaming-pump mechanism, bottle size, package compatibility and destination-market requirements are reviewed together before sampling or production. We coordinate pump selection, foam-performance testing, private label packaging, finished-product quality control, project-specific documentation and commercial production planning. Intended users, directions, warnings, claims and market authorization must be confirmed for the specific finished product and country before commercial distribution.
The old page calls the product “foam,” “mousse” and “hair foam” but does not identify a valve, propellant or aerosol can. Its bottle sizes are shown in millilitres and its shipping fields treat it like an ordinary bottle. These details suggest a mechanical foaming pump, but the actual package must be checked.
Use this new page and verify that the formula reliably generates foam through the selected non-pressurized pump.
Do not keep another duplicate page. Redirect this URL to the existing Minoxidil Topical Foam category or the appropriate aerosol-foam product.
| Project factor | Mechanical pump foam | Pressurized aerosol foam |
|---|---|---|
| Dispensing principle | Pump combines liquid product with air through a foaming mesh | Pressurized formula discharges through a valve and actuator |
| Primary package | Bottle, foaming pump, closure and cap | Pressure can, valve, actuator and cap |
| Key tests | Priming, pump output, foam density, clogging and leakage | Pressure, crimp, leakage, discharge rate and foam quality |
| Transport review | Depends on the confirmed formula and route | Pressurized-product classification and carrier restrictions apply |
A mechanical foaming pump requires the liquid formula to pass through an internal mesh and form stable foam when mixed with air. Viscosity, solvent composition, surface behavior, suspended matter and crystallization can affect priming, output, clogging and foam structure.
Multiple bottle sizes can support different retail strategies, but each size needs a compatible pump and validated fill configuration. The same pump may not deliver identical performance across containers with different headspace, dip-tube length and geometry.
Available sizes should be confirmed from actual packaging inventory before publication. Label dimensions, net-contents declaration, carton size, batch code and destination-market text must be prepared for each approved pack rather than copied across all variants.
A test plan is established for the confirmed formula and pump package. In addition to active-content and stability requirements, the foaming mechanism requires functional checks.
The old page provides a capful dosage, twice-daily use, a four-hour no-wash period, a two-to-four-month result timeline and one universal answer for men and women. These instructions should not remain on a B2B project page.
Intended users, directions, warnings, contraindications and expected claims must come from the applicable product pathway and finished label. KINODIN’s page should describe formula, packaging, testing, MOQ and documentation support without prescribing one consumer regimen globally.
The current 20-bottle MOQ should not be presented as a universal OEM production quantity unless it refers to an available finished stock product with label-only service. Sample quantity, label-only trial quantity and custom-production MOQ are three different commercial terms.
Private label options may include bottle color, foaming pump, protective cap, label, direct decoration, carton and batch coding. MOQ and lead time depend on the confirmed formula, packaging size, print method, testing and documentation requirements.
Available documents depend on the actual formula, manufacturing party, pump package, batch and destination market. Project files may include formula information, raw-material documents, safety data, batch COA, test reports, packaging specifications and manufacturing records, depending on scope.
The customer and its regulatory partner must establish the applicable registration or marketing-authorization route, authorization holder, importer, responsible party, intended users, label, directions, warnings and claims. Generic factory or ingredient documents do not authorize a customized finished product.
The new positioning assumes a non-pressurized mechanical foaming pump. The physical package must be confirmed before publishing the page.
Those terms can suggest a cosmetic styling product. “Minoxidil topical pump foam” more accurately describes the intended dosage form and dispenser.
They remain proposed options only. Actual bottle, pump, dip-tube and fill compatibility must be confirmed for each size.
Intended users, concentration, directions and warnings must follow the specific product pathway and destination market. The page does not make a universal claim.
That may describe a stock or label-only trial rather than custom production. Final MOQ is separated into samples, stock private label and customized manufacturing.
Pump style, bottle, color, cap, label and carton can be evaluated subject to formula compatibility, component availability and MOQ.
Sample availability is confirmed after formula and pump selection. A sample does not replace stability, batch testing or market authorization.
Tests may include priming, output per actuation, foam density, collapse, leakage, clogging and performance through the expected pack-use period.
The document list is confirmed for the actual formula, manufacturing party, pump package, batch and destination market.
Send a package photo, destination country, intended users, preferred bottle size, private label requirements and estimated quantity. KINODIN will confirm whether the system is pump foam, then review formula, packaging, testing and documentation.
Minoxidil Topical Products Minoxidil Topical FoamRegulatory Notice: Minoxidil-containing products may be regulated as medicinal products in the destination market. Formula, intended users, labeling, claims, directions, warnings, packaging and supporting documents must be evaluated for the intended country. KINODIN does not represent that a customized finished product is authorized in any specific market unless supported by the applicable authorization documents.
contact us
contact us for free sample !
Copyright © 2026 Foshan Younik Cosmetics Co., Limited. All Rights Reserved.